Alzheimer’s disease market expected to reach $14.7bn across the 8MM by 2033
The Alzheimer’s disease market is expected to grow at a high compound annual growth rate (CAGR) of 20.0% from $2.4…
All articles by GlobalData Healthcare
GlobalData Healthcare
-
-
MimiVax announces disappointing pivotal Phase IIb trial data for cancer vaccine
The pivotal SURVIVE Phase IIb trial for SurVaxM, a glioblastoma (GBM) peptide-mimic immunotherapeutic cancer vaccine developed by MimiVax, announced interesting…
-
Parkinson’s disease market expected to reach $7.2bn across the 7MM by 2033
The Parkinson’s disease (PD) market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and…
-
EASD 2026: GLP-1 and SGLT2 treatment lowers mortality in heart failure patients
At the 2026 European Association for the Study of Diabetes (EASD) Annual Meeting, retrospective research was presented that showed initial…
-
EASD 2026: TRIUMPH-2 data puts retatrutide above the incretin ceiling in T2D
On 30 September, at the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan,…
-
EASD 2026: Petrelintide pairs 10.7% weight loss with placebo-like GI tolerability
On September 30, at the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan,…
-
EASD 2026: Roche’s enicepatide shows 22.7% placebo-adjusted weight loss at 48 weeks
On 30 September, at the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan,…
-
EASD 2026: Semaglutide shows promise in treating obesity-related heart failure
At the 2026 European Association for the Study of Diabetes (EASD) Annual Meeting, research was presented that showed encouraging results…
-
EASD 2026: Oral semaglutide drives weight loss after switch from injectable GLP-1s
This year at the European Association for the Study of Diabetes (EASD) Annual Meeting, real-world data from the OCTANE study…
-
EASD 2026: CagriSema weight loss holds at submaximal doses in REDEFINE-1 analysis
On 29 September, at the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan,…